Control | Case | |||||||
---|---|---|---|---|---|---|---|---|
Low (n = 37) | High (n = 68) | P value | P value* | Low (n = 72) | High (n = 33) | P value | P value* | |
Demographic characteristic | ||||||||
Age (y) | 54.06 ± 6.555 | 56.12 ± 7.428 | 0.16 | – | 55.44 ± 7.082 | 54.76 ± 7.483 | 0.65 | – |
Albumin (g/dl) | 12.58 ± 7.602 | 6.11 ± 5.097 | < 0.001 | < 0.001 | 15.56 ± 13.158 | 13.09 ± 10.001 | 0.34 | 0.34 |
ACR | 19.65 ± 6.212 | 18.09 ± 5.766 | 0.20 | 0.07 | 239.74 ± 91.266 | 217.67 ± 145.891 | 0.35 | 0.42 |
Diabetes duration (y) | 7.67 ± 2.111 | 7.49 ± 2.222 | 0.70 | 7.65 ± 2.184 | 7.50 ± 2.305 | 0.75 | ||
Blood pressure | ||||||||
SBP (mmHg) | 121.72 ± 16.554 | 133.00 ± 122.428 | 0.58 | 0.69 | 128.61 ± 16.597 | 123.64 ± 19.272 | 0.18 | 0.08 |
DBP (mmHg) | 81.53 ± 13.064 | 79.25 ± 11.096 | 0.35 | 0.67 | 84.83 ± 14.064 | 78.33 ± 9.746 | 0.01 | 0.04 |
Anthropometry characteristic | ||||||||
Body weight (kg) | 69.686 ± 12.9626 | 72.722 ± 10.6348 | 0.20 | 0.30 | 73.561 ± 12.4596 | 72.182 ± 16.2292 | 0.64 | 0.63 |
Height (cm) | 163.36 ± 4.673 | 159.93 ± 6.177 | 0.004 | < 0.001 | 160.35 ± 6.348 | 161.79 ± 6.294 | 0.28 | 0.36 |
BMI (kg/m2) | 26.028 ± 4.9568 | 28.367 ± 3.8442 | 0.009 | 0.07 | 28.586 ± 4.7848 | 28.356 ± 3.9868 | 0.81 | 0.79 |
Blood parameters | ||||||||
Hb (mg/dl) | 12.456 ± 1.2796 | 12.753 ± 1.1719 | 0.23 | 0.19 | 12.439 ± 1.3583 | 13.112 ± 1.3188 | 0.02 | 0.18 |
FBS (mg/dl) | 161.92 ± 45.779 | 149.81 ± 44.668 | 0.19 | 0.57 | 168.71 ± 53.292 | 160.79 ± 47.320 | 0.47 | 0.03 |
BS (mg/dl) | 217.22 ± 52.193 | 201.62 ± 55.460 | 0.16 | 0.36 | 220.26 ± 58.710 | 210.42 ± 43.663 | 0.39 | 0.07 |
HbA1c (%) | 8.44 ± 1.21 | 7.79 ± 1.28 | 0.01 | 0.10 | 8.74 ± 1.38 | 8.33 ± 1.44 | 0.17 | 0.02 |
Cholesterol (mg/dl) | 180.69 ± 25.829 | 172.26 ± 35.373 | 0.21 | 0.39 | 187.83 ± 36.408 | 183.45 ± 41.200 | 0.59 | 0.87 |
TG (mg/dl) | 164.31 ± 49.132 | 159.75 ± 61.630 | 0.70 | 0.87 | 163.83 ± 56.674 | 171.91 ± 81.388 | 0.56 | 0.41 |
LDL (mg/dl) | 103.97 ± 29.577 | 89.10 ± 28.167 | 0.01 | 0.10 | 108.80 ± 33.345 | 103.73 ± 27.924 | 0.45 | 0.91 |
HDL (mg/dl) | 46.00 ± 8.903 | 46.59 ± 9.553 | 0.76 | 0.93 | 44.88 ± 9.421 | 43.82 ± 8.041 | 0.58 | 0.87 |
Cr (mg/dl) | 0.86 ± 0.14 | 0.87 ± 0.18 | 0.79 | 0.03 | 0.9480 ± 0.16718 | 0.8679 ± 0.14339 | 0.02 | 0.18 |
BUN (mg/dl) | 16.50 ± 4.398 | 14.43 ± 3.374 | 0.009 | 0.007 | 15.67 ± 4.086 | 15.76 ± 5.657 | 0.93 | 0.89 |
Qualitative variables | ||||||||
PA (met-h/w) | ||||||||
Low (> 600) | 13 (35.1) | 24 (64.9) | 0.79 | 20 (66.7) | 10 (33.3) | 0.89 | ||
Moderate (600–3000) | 9 (29.6) | 19 (70.4) | 33 (67.5) | 13 (32.5) | ||||
High (< 3000) | 15 (37.5) | 25 (62.5) | 19 (66.5) | 10 (34.5) | ||||
Medical history | ||||||||
Positive CVD history | 10 (43.5) | 13 (56.5) | 0.31 | 14 (63.6) | 8 (36.4) | 0.73 | ||
Medication usage | ||||||||
ARBs | 16 (35.6) | 29 (64.4) | 0.86 | 36 (64.3) | 20 (35.7) | 0.56 | ||
ACEIs | 9 (45) | 11 (55) | 0.27 | 29 (67.4) | 14 (32.6) | 0.88 | ||
Beta blockers | 7 (38.9) | 11 (61.1) | 0.67 | 13 (68.4) | 6 (31.6) | 0.36 | ||
Metformin | 35 (34) | 68 (66) | 0.34 | 65 (66.3) | 33 (33.7) | 0.99 | ||
sulfonylurea | 22 (36.1) | 39 (63.9) | 0.71 | 43 (65.2) | 23 (34.8) | 0.65 | ||
Insulin | 12 (34.3) | 23 (65.7) | 0.96 | 20 (76.9) | 6 (23.1) | 0.19 |